Kanglong Chemical: On March 20, net short selling of 1,400 shares, cumulative net short selling of 6,600 shares over 3 consecutive days

NightAirdropper · 2026-03-24T06:37:30+00:00

On March 20th, Kanglong Pharmatech had a net margin financing outflow of 8.4319 million yuan, with a margin financing balance of 1.065 billion yuan. Among the last 20 trading days, 11 days showed net inflows. Regarding short selling, there was a net outflow of 1,400 shares, with a short selling balance of 1.115 million shares. The total margin financing and short selling balance was 1.067 billion yuan, down 0.79% from the previous day.

NightAirdropper

2026-03-24 06:37:30

Abstract generation in progress

Securities Star News: On March 20, Kanglong Chemical (300759) had a margin buy-in of 33.941 million yuan, a margin repayment of 42.3729 million yuan, a net margin sell of 8.4319 million yuan, with a margin balance of 1.065 billion yuan. In the past 20 trading days, there have been 11 days of net margin buying.

Regarding securities lending, on that day, 1,600 shares were sold short, 200 shares were repaid, resulting in a net short sale of 1,400 shares. The remaining securities lending balance is 111,500 shares. Over the past three trading days, there has been a continuous net sale totaling 6,600 shares.

The total margin and securities lending balance is 1.067 billion yuan, down 0.79% from yesterday.

Quick Facts

Margin Trading and Securities Lending: The margin balance refers to the difference between the amount borrowed to buy stocks and the amount repaid. An increase in margin balance indicates investor bullish sentiment and a strong market; a decrease suggests a weak market. The securities lending balance is the difference between the amount of securities sold short and the amount repaid. An increase in securities lending balance indicates a seller’s market; a decrease suggests a buyer’s market.

The above content is compiled from public information by Securities Star, generated by AI algorithm (Wangxin Calculation Backup No. 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.